阿片类药物阻断了抑制性突触的长期增强
Fereshteh S Nugent1, Esther C Penick, Julie A Kauer
1Brown University, Department of Molecular Pharmacology, Physiology and Biotechnology, Providence, Rhode Island 02912, USA.
Nature
|April 27, 2007
概括
研究人员在大脑中发现了一种新型的突触可塑性.
科学领域:
- 神经科学是一个神经科学.
- 突触性可塑性 突触性可塑性
- 神经药理学神经药理学
背景情况:
- 突触可塑性,突触强度的变化,是学习和成的基础.
- 抑制GABA (氨酸) 释放突触的可塑性是不太了解的.
- 腹膜区域对于药物成的发展至关重要.
研究的目的:
- 研究GABA (A) 介导的突触传递 (LTP (GABA)) 对多巴胺神经元的长期增强.
- 探索这种新型突触可塑性背后的机制.
- 为了研究吗啡对LTP的作用 (GABA).
主要方法:
- 在老鼠大脑切片中的电生理学记录.
- 研究了需要NMDA受体激活的异质突触可塑性.
- 利用氧化作为一个逆行信号分子.
主要成果:
- 识别了LTP (GABA) 进入腹部体区域的多巴胺神经元.
- 证明LTP (GABA) 是异质突触的,由NMDA受体诱导的氧化介导.
- 表明,在体外和体内暴露于吗啡,都能防止LTP(GABA).
结论:
- 在LTP (GABA) 中的阿片类药物诱导的神经适应可能会导致成.
- 新的机制涉及从多巴胺神经元到GABA终端的氧化信号传输.
- 针对GABA (A) 受体的治疗策略可能是有益的.
相关概念视频
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Hebbian LTP
LTP can occur when presynaptic neurons...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...


